200 related articles for article (PubMed ID: 3873952)
1. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
2. [Immunological monitoring of brain tumors--prognosis and cellular immunity of patients with brain tumors].
Yokoyama H; Hara M; Ogashiwa M; Takeuchi K
No To Shinkei; 1983 Nov; 35(11):1103-8. PubMed ID: 6661336
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistological analysis of infiltrating lymphocyte subpopulations in gliomas and metastatic brain tumors].
Saito T; Tanaka R; Kouno M; Takai N; Yoshida S; Hara N; Washiyama K; Sekiguchi K; Kumanishi T
No To Shinkei; 1987 Apr; 39(4):339-45. PubMed ID: 2439110
[TBL] [Abstract][Full Text] [Related]
4. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.
Shiratsuchi H; Tsuyuguchi I
Clin Exp Immunol; 1984 Aug; 57(2):271-8. PubMed ID: 6331920
[TBL] [Abstract][Full Text] [Related]
5. [Immunological examination in patients with brain tumor and the usefulness of PHA skin test (author's transl)].
Imagawa K; Tochio H; Toda I; Hayashi M; Asai A; Nomura T; Miyaji H
No To Shinkei; 1978 Nov; 30(11):1171-6. PubMed ID: 728272
[TBL] [Abstract][Full Text] [Related]
6. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
[TBL] [Abstract][Full Text] [Related]
7. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of tumor specific immunological response in the patients with malignant brain tumors by the mixed lymphocyte-tumor cell reaction].
Yoshida S; Takai N; Ono K; Saito T; Tanaka R
No To Shinkei; 1988 Nov; 40(11):1067-73. PubMed ID: 2975495
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the immunosuppressive mechanism in patients with malignant brain tumors].
Yoshida S
No To Shinkei; 1985 Dec; 37(12):1137-43. PubMed ID: 3879181
[TBL] [Abstract][Full Text] [Related]
10. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
Blomgren H; Blom U; Ullén H
Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
[TBL] [Abstract][Full Text] [Related]
11. [Clinicoimmunological values of measurement of IgG-Fc receptor positive T cells in the patients with malignant brain tumors].
Yoshida S; Hara N; Takai N; Saito T; Tanaka R
No To Shinkei; 1985 Nov; 37(11):1073-8. PubMed ID: 2934080
[TBL] [Abstract][Full Text] [Related]
12. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
13. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
14. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory T cells in measles. The relationship between reduced lymphocyte proliferative response to PHA and increased proportion of circulating suppressor-cytotoxic T cells.
Bertotto A; Rambotti A; Gentilini F; Stefanelli M; Zucchetti P; Vaccaro R
Microbiologica; 1984 Jan; 7(1):21-7. PubMed ID: 6233473
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte subpopulations and their functional activity in patients with brain tumors].
Rudenko VA; Lisianyĭ NI; Radzievskiĭ AA
Vrach Delo; 1990 Sep; (9):91-4. PubMed ID: 2284786
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.
Peres E; Wood GW; Poulik J; Baynes R; Sood S; Abidi MH; Klein J; Bhambhani K; Dansey R; Abella E
Neuropediatrics; 2008 Jun; 39(3):151-6. PubMed ID: 18991194
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
